Katon W, Von Korff M, Lin E, Walker E, Simon G, Robinson P, Bush T, Irvin S
Department of Psychiatry and Behavioral Sciences, University of Washington Medical School, Seattle 98195.
Psychosom Med. 1994 Mar-Apr;56(2):97-103. doi: 10.1097/00006842-199403000-00004.
Most anxiety, depressive, and substance abuse disorders are treated exclusively in the primary care health system. However, recognition and treatment of these disorders in primary care is deficient. Psychopharmacologic and psychotherapeutic interventions have been developed and proven effective in randomized trials in specialty care. However, the results of successful trials of mental health interventions in specialty settings may not generalize to primary care settings because of epidemiologic differences in patients, differences in skills of providers, as well as differences in the very structure of care. The importance of the development of innovative randomized trials to improve recognition and treatment of mental illness in primary care is emphasized, as well as the methodologic problems inherent in carrying out these trials.
大多数焦虑症、抑郁症和药物滥用障碍仅在初级保健卫生系统中得到治疗。然而,初级保健中对这些障碍的识别和治疗存在不足。心理药理学和心理治疗干预措施已经开发出来,并在专科护理的随机试验中被证明是有效的。然而,由于患者的流行病学差异、提供者技能的差异以及护理结构本身的差异,专科环境中成功的心理健康干预试验结果可能无法推广到初级保健环境。强调了开展创新性随机试验以改善初级保健中精神疾病的识别和治疗的重要性,以及开展这些试验所固有的方法学问题。